Is Soligenix Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Soligenix Inc (SNGX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Soligenix Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Soligenix Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Soligenix Inc?

Muslim investors may consider investing in Soligenix Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Soligenix Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Soligenix Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Soligenix Inc updated?

The Shariah compliance status of Soligenix Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Soligenix Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Soligenix Inc?

You can check the latest Shariah compliance status of Soligenix Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SNGX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 03, 2026

Report Source: 2025 Annual Report

Soligenix Inc. Stock Analysis SNGX

United States Health Care Nano Cap Report: 2025 Annual

Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 13 full-time employees. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).

Key Statistics of Soligenix Inc (SNGX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.35$0.40

Today's Open

$0.40

Volume

635.04K

P/E Ratio (TTM)

52 Week Range

$0.28$6.23

Market Cap

3.28M

Avg. Volume

1.49M

Dividend Yield

Financial Metrics & Statements of Soligenix Inc (SNGX)

FAQ's for Soligenix Inc (SNGX)

According to Musaffa’s Shariah screening methodology, Soligenix Inc (SNGX) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.